Atlas Trials

Combination Chemotherapy and Imatinib Mesylate in Treating Patients With Extensive-Stage Small Cell Lung Cancer

Clinical trial NCT00052494 · COMPLETED

Trial details

NCT number
NCT00052494
Sponsor
University Health Network, Toronto
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Lung Cancer
Start date
2003-04-01
Primary completion
2009-02-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.